Cite
HARVARD Citation
Soyka, M. et al. (2023). Predicting dupilumab treatment outcome in patients with primary diffuse type 2 chronic rhinosinusitis. Allergy. 78 (4), pp. 1036-1046. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Soyka, M. et al. (2023). Predicting dupilumab treatment outcome in patients with primary diffuse type 2 chronic rhinosinusitis. Allergy. 78 (4), pp. 1036-1046. [Online].